Vanguard Group Inc Biote Corp. Transaction History
Vanguard Group Inc
- $6.44 Trillion
- Q3 2025
A detailed history of Vanguard Group Inc transactions in Biote Corp. stock. As of the latest transaction made, Vanguard Group Inc holds 1,426,951 shares of BTMD stock, worth $3.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,426,951
Previous 1,423,583
0.24%
Holding current value
$3.6 Million
Previous $5.72 Million
25.2%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BTMD
# of Institutions
88Shares Held
15.4MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$11.5 Million4.62% of portfolio
-
Bandera Partners LLC New York, NY2.28MShares$5.76 Million3.0% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$4.04 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA695KShares$1.75 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA612KShares$1.54 Million0.0% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $19.1M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...